secwatch.observer — SEC 8-K summary
======================================

Issuer:     BiomX Inc. (PHGE)
CIK:        0001739174
Form:       8-K
Filed at:   2026-03-11T23:59:59+00:00
Accession:  0001213900-26-026174
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

BiomX stockholders approve share issuance above 19.99% threshold for financing
------------------------------------------------------------------------------

- At special meeting on March 11, 2026, stockholders approved issuance of common shares exceeding 19.99% of outstanding for conversion of Series Y preferred and warrants.
- Proposal 1 received 528,511 votes for, 23,714 against, and 4,753 abstentions.
- Proposal 2 (adjournment) received 524,578 for, 31,778 against, and 622 abstentions; adjournment not needed.
- Record date was Feb 3, 2026; 1,593,516 shares of common stock outstanding and entitled to vote.
- Approval relates to a securities purchase agreement dated Dec 26, 2025 and engagement with H.C. Wainwright & Co.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026026174/0001213900-26-026174-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026026174/ea028113901-8k_biomx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-026174

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer